Acquisition

06th October, 2026 To, To, The Secretary, The Secretary, Bombay Stock Exchange Ltd (BSE) National Stock Exchange (NSE), Phiroze Jheejheebhoy Towers, Exchange Plaza, Dalal Street, 5th Floor Plot No.C/1, 'G' Block Mumbai - 400 001. Bandra - Kurla Complex Scrip Code - 543308 Mumbai - 400 051. ISIN: INE967H01025 Symbol - KIMS Dear Sir/ Madam Sub: Intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Acquisition of Equity Stake in Splendid Hospitals Private Limited (Kompally), an O & M entity by investing upto Rs. 40.00 Cr, by way of primary infusion – Reg. Pursuant to provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors of Krishna Institute of Medical Sciences Limited (“the Company”) at its meeting held on today, i.e. 06th October, 2026 has approved the proposal for acquisition of equity stake of Splendid Hospitals Private Limited (Kompally), an O & M entity by investing upto Rs. 40.00 Cr, by way of primary infusion. We enclose herewith the details required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 as an Annexure-1 to this letter. Kindly take the above intimation on your records. This intimation is also uploaded on the Company’s website at: https://www.kimshospitals.com/investors/ > Disclosures under Regulation 62 of the SEBI (LODR) Regulations, 2015 > Intimations filed by the Company > Intimations under Regulation 30. Thanking You, Yours truly For Krishna Institute of Medical Sciences Limited Nagajayanthi J.R Company Secretary and Compliance Officer ANNEXURE -1 a Name of the target entity, details in brief such Name of the target entity: Splendid Hospitals as size, turnover, etc., Private Limited (Kompally). Details in brief: SPLENDID HOSPITALS PRIVATE LIMITED (‘Splendid’), is a company incorporated and existing under the Companies Act, 2013 and having its registered office at Plot no 339/340 road no.4 Remedy Hospitals KPHB Colony Kukatpally, Hyderabad, Telangana, 500072. The hospital has the potential due to the location and demand for hospital services and has the capacity to expand to over 225+ beds and is equipped with the latest medical infrastructure, medical and diagnostic equipment, and multiple operation theatres. (Rs. in Crore) FY 2025-26 Turnover: 1.39 PAT: -8.92 Networth: 38.69 b Whether the acquisition would fall within Acquisition of equity shares does not fall within related party transaction(s) and whether the the definition of Related Party Transaction. promoter / promoter group / group companies have any interest in the entity being acquired? If yes, nature of Interest and details thereof and whether the same is done at "Arms length": c Industry to which the entity being acquired Healthcare Industry belongs: d Objects and effects of acquisition (including but KIMS being the O & M Partner of the target entity not limited to, disclosure of reasons for has decided to acquire the equity stake as a acquisition of target entity, if its business is strategic investment. outside the main line of business of the listed entity e Brief details of any governmental or regulatory Not Applicable. approvals required for the acquisition: f Indicative time period for completion of the On or before 31.03.2027. acquisition g Consideration - whether cash consideration or Cash. share swap and details of the same: h Cost of acquisition or the price at which the The shares will be acquired based on the valuation shares are acquired; report issued by BDO Valuation Advisory LLP, dated 05th October, 2026, for an aggregate consideration of up to ₹40.00 Crore (Rupees Fourty Crore only). i Percentage of shareholding/control acquired KIMS will acquire upto 22% of equity shares of and/or number of shares acquired; Rs. 10 each, for an aggregate consideration of upto ₹40.00 Crore (Rupees Fourty Crore only), by way of primary infusion. j Brief background about the entity acquired in Brief background about the entity acquired: As terms of products/line of business acquired, mentioned in serial no. (a) date of incorporation, history of last 3 years turnover, country in which the acquired entity Date of Incorporation: 20-09-2022 has presence, and any other significant information (in brief): History of last 3 years Total Turnover of the Company: Particulars Amount in Crores FY26 1.39 FY25 0.30 FY24 0.00 Presence: Kompally, Telangana - India Other Significant Information: please refer to the aforementioned.